Page results
-
Breakthroughs in Alzheimer’s disease are exciting and invigorating dementia research, and we will need to be ready to deliver new treatments as they come through, say Professor Nick Fox and Dr Catherine Mummery.
-
Medtronic are running a series of patient webinars for anyone with Type 1 Diabetes using the MiniMed™ 780G pump or system.
-
New precision therapy for bile duct cancer extends patients’ lives
-
Information about endovascular treatments of AVMs undertaken in the NHNN angiography suite.
-
Information about coil embolisations and how endovascular treatment is used to treat cerebral aneurysms.
-
Cancer surgery at UCLH on Operation Ouch
-
Ensuring that UCLH staff understand the urgency of the climate crisis and support our net zero programme is crucial if we want to be successful in reaching our goal of net zero carbon emissions by 2031. Our patients must be kept informed of changes and we must work closely with other NHS organisations, including NHS England, if we are to deliver a successful programme. This page documents our progress to date.
-
Medtronic are discontinuing the MiniMed™ Mio™ Infusion sets. If you are currently using MiniMed™ Mio™ infusion sets, you will need to change to an alternative infusion set before 31 March 2023. After this date, MiniMed™ Mio™ infusion sets will no longer be available.
-
Preterm infants do not get used to repeated pain in the way that full-term infants, children and adults do habituate to pain, finds a study at UCLH and UCL.
-
Well done to everyone who ran to support UCLH in the iconic London Landmarks Half Marathon on 2 April!
File results
-
FOI/2023/0117 - EPRR Team contact information
-
FOI/2023/0115 - Deaths in A&E
-
FOI/2023/0114 - Electronic Patient Record/ Electronic Health Record systems
-
FOI/2023/0111 - Migraine treatment
-
FOI/2023/0110 - General anaesthesia paediatric dental waiting times
-
FOI/2023/0109 - UK-EU aggrement S2 funding applications and treatments
-
FOI/2023/0105 - Maternity services birthing centre
-
FOI/2023/0080 - Treatment for Myeloid leukaemia (AML) and chronic lymphocytic leukaemia
-
FOI/2023/0075 - Attrition rates for staff working in advanced practice roles
-
FOI/2023/0073 - Telephony and UC/ collaboration, Microsoft 365 licence and on-premise or cloud storage